Monashee Investment Management »

Springworks Therapeutics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.7M 74k 36.50
2021-09-30 $3.6M 57k 63.44
2021-06-30 $3.7M 45k 82.40
2021-03-31 $2.6M 35k 73.57
2019-09-30 $1.8M 83k 21.68

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Springworks Therapeutics

Vanguard Group
Boxer Capital
OrbiMed Advisors
Marshall Wace
Maverick Capital
T. Rowe Price Associates
Deerfield Management Company
Point72 Asset Management
Arrowpoint Asset Management
Perceptive Advisors
Artal Group
Dimensional Fund Advisors
Fiera Capital Corporation
Jpmorgan Chase & Co
Victory Capital Management

View all funds holding Springworks Therapeutics